Description
A triacetylated derivative of resveratrol that has diverse biological activities; inhibits the growth of LNCaP, DU145, and PC3M prostate cancer cells (IC50s = 10.5, 14.2, and 26.8 μM, respectively); induces cytotoxicity in ALL-5 acute lymphoblastic leukemia cells (IC50 = 3.4 μM) and induces cell cycle arrest at the G1 phase at 17 μM; increases survival in mice exposed to total body γ-irradiation at 10 mg/kg prior to irradiation
Formal name: 5-[(1E)-2-[4-(acetyloxy)phenyl]ethenyl]-1,3-benzenediol, 1,3-diacetate
Synonyms: 3,5,4′-Tri-O-acetylresveratrol|Resveratrol triacetate|Triacetylresveratrol
Molecular weight: 354.4
CAS: 42206-94-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Research Area|Cancer|Cell Cycle|G1||Research Area|Cancer|Cell Death||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity